M. Hinchcliffe - Concepedia

Author

M. Hinchcliffe

West Pharmaceutical Services (United Kingdom)

Also Known As

M Hinchcliffe, M. Hinchcliffe, Martyn Hinchcliffe

Publications

1.8K

Citations

H-Index

Concepts

All Affiliations

West Pharmaceutical Services (United Kingdom)University of Nottingham Albert Einstein College of Medicine

About

M. Hinchcliffe is an author at West Pharmaceutical Services (United Kingdom) specializing in medicine, vaccination, and vaccine development.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	266
2	Education	1	1	123
3	Public Health	1	1	21
4	Allergy	1	1	36
5	Biomedical Engineering	1	1	162

M. Hinchcliffe

Publications

Citations

H-Index

Page 1

	Year	Citations
Nasal Delivery of Insulin Using Novel Chitosan Based Formulations: A Comparative Study in Two Animal Models Between Simple Chitosan Formulations and Chitosan Nanoparticles A. M. Dyer, M. Hinchcliffe, Peter Watts, Pharmaceutical Research	2002	280
Clearance characteristics of chitosan based formulations in the sheep nasal cavity R. J. Soane, M. Hinchcliffe, S.S. Davis, International Journal of Pharmaceutics Clearance CharacteristicsSheep Nasal CavityBiomedical Engineering	2001	162
Intranasal Delivery of Morphine Lisbeth Illum, Peter Watts, A.N. Fisher, Journal of Pharmacology and Experimental Therapeutics	2002	159
Carbohydrate Biopolymers Enhance Antibody Responses to Mucosally Delivered Vaccine Antigens Andrew Bacon, J. Makin, Philip J.H. Sizer, Infection and Immunity	2000	150
Gastrointestinal transit of dosage forms in the pig S.S. Davis, Lisbeth Illum, M. Hinchcliffe Journal of Pharmacy and Pharmacology NutritionSolid Dosage FormsGastrointestinal PharmacologyGastroenterologyEducation	2001	123
An intranasal vaccine targeting both the Bacillus anthracis toxin and bacterium provides protection against aerosol spore challenge in rabbits S. Wimer-Mackin, M. Hinchcliffe, Carey R. Petrie, Vaccine VaccinationMucosal VaccinationVaccine DevelopmentMedicineVaccine Target	2006	47
A single immunization with a dry powder anthrax vaccine protects rabbits against lethal aerosol challenge Sheri D Klas, Carey R. Petrie, Sarah J. Warwood, Vaccine VaccinationVaccinologyMucosal VaccinationVaccine DevelopmentImmunology	2008	39
Cyclodextrins as protection agents against enhancer damage in nasal delivery systems II. Effect on in vivo absorption of insulin and histopathology of nasal membrane I. Jabbal Gill, A.N. Fisher, M. Hinchcliffe, European Journal of Pharmaceutical Sciences AllergyMedicineProtection AgentsCyclodextrin ProductionTopical Drug	1994	36
Provocation and amplification of the transvalvular pressure gradient in rheumatic tricuspid stenosis Paulo A. Ribeiro, Muayed Al Zaibag, Saad Al Kasab, The American Journal of Cardiology Valve DiseaseRheumatic Tricuspid StenosisValvular Heart DiseasePublic HealthMedicine	1988	21
The Effect of Blood Sampling Site and Physicochemical Characteristics of Drugs on Bioavailability After Nasal Administration in the Sheep Model Lisbeth Illum, M. Hinchcliffe, S.S. Davis Pharmaceutical Research	2003	18

Page 1